There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Stay Physically Active, Follow a Balanced Diet, Prioritize Medication Management, Engage in Cognitive Exercises, Build a ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only ...

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

With no known cure for Parkinson’s, the disease progresses rapidly ... “No one should have to choose between life-changing medication, food and shelter,” Lee said. John has experienced ...

A Rutgers Health study has found that people who took multiple courses of penicillin antibiotics had a modestly lower risk of ...

They compared 12,557 people diagnosed with Parkinson's to 80,804 similar individuals without the disease. In addition ... such as patient diet. Still, Pal said the findings support further ...

Dozens of neurologists are calling on the Australian chemicals regulator to ban paraquat, a toxic herbicide that has been linked to the development of Parkinson's disease.

Nilotinib, a drug approved by the US Food and Drug Administration (FDA ... and the International Parkinson and Movement ...